Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:dateCreated
2006-5-24
pubmed:abstractText
Brain arteriovenous malformations (BAVM) have high matrix metalloproteinase-9 (MMP-9) expression, the source of which is unclear. We hypothesized MMP-9 production might be due to inflammation in BAVM. Compared to control brain tissues (n = 5), BAVM tissue (n = 139) had a higher expression (by ELISA) of myeloperoxidase (MPO) (193 +/- 189 vs. 6 +/- 3, ng/mg, P < .001), MMP-9 (28 +/- 32 vs. 0.7 +/- 0.6, ng/mg, P < .001), and IL-6 (102 +/- 218 vs. 0.1 +/- 0.1, pg/mg, P < .001), but not eNOS (114 +/- 87 vs. 65 +/- 9, pg/mg, P = .09). MMP-9 expression in BAVM highly correlated with myeloperoxidase (R2 = .76, P < .001), as well as with IL-6 (R2 = .32, P < .001). In contrast, MMP-9 in BAVM poorly correlated with the endothelial marker, eNOS (R2 = .03, P = .05), and CD31 (R2 = .004, P = .57). Compared to non-embolized patients (n = 46), patients with pre-operative embolization (n = 93) had higher levels of myeloperoxidase (236 +/- 205 vs. 106 +/- 108, ng/mg, P < .001) and MMP-9 (33 +/- 35 vs. 16 +/- 20, ng/mg, P < .001), however the correlation between MMP-9 and myeloperoxidase was equally strong for both groups (R2 = .69, n = 93, P < .001, for both). MMP-9 expression correlated with the lipocalin-MMP-9 complex, suggesting neutrophils as the MMP-9 source. MPO co-localized with majority of MMP-9 signal by immunohistochemistry. Our data suggest that inflammation is a prominent feature of BAVM lesional phenotype, and neutrophils appear to be a major source of MMP-9 in these lesions.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:issn
1093-4715
pubmed:author
pubmed:issnType
Electronic
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
3121-8
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:16720380-Adult, pubmed-meshheading:16720380-Antigens, CD31, pubmed-meshheading:16720380-Biological Markers, pubmed-meshheading:16720380-Case-Control Studies, pubmed-meshheading:16720380-Embolization, Therapeutic, pubmed-meshheading:16720380-Endothelial Cells, pubmed-meshheading:16720380-Female, pubmed-meshheading:16720380-Humans, pubmed-meshheading:16720380-Inflammation, pubmed-meshheading:16720380-Interleukin-6, pubmed-meshheading:16720380-Intracranial Arteriovenous Malformations, pubmed-meshheading:16720380-Leukocytes, pubmed-meshheading:16720380-Male, pubmed-meshheading:16720380-Matrix Metalloproteinase 9, pubmed-meshheading:16720380-Neutrophils, pubmed-meshheading:16720380-Nitric Oxide Synthase Type III, pubmed-meshheading:16720380-Peroxidase, pubmed-meshheading:16720380-Prospective Studies
pubmed:year
2006
pubmed:articleTitle
MMP-9 expression is associated with leukocytic but not endothelial markers in brain arteriovenous malformations.
pubmed:affiliation
Center for Cerebrovascular Research, Department of Anesthesia and Perioperative Care, University of California, San Francisco, CA 94110, USA.
pubmed:publicationType
Journal Article, Comparative Study, Research Support, N.I.H., Extramural